Event Type
Disclosure
Mandatory
Variant
8-K
Termination of a Material Definitive Agreement. On November 26, 2025, Daré Bioscience, Inc. (“we,” “us”, “our,” or the “Company”) received notice from Bayer Hea
and in Exhibit 99.1 to this report is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, a
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press release issued on December 1, 2025 104 Cover Page Interactive Data File (embed